Just establishing a protocol thatstops cancer from spreading at all is a huge discovery. Setting aside the desirability of an actualcure and actually halting the body’s collapse from the ravages of the diseaseis a very useful result as we have learned in the war on AIDS. You do not die from AIDS today because the diseaseis stabilized with the cocktail. In facta reversal of damage is achieved and the victim is on the way to dying from oldage.
Many cancer growths remain benignand if the problem is halted then they remain so. Thus cancer therapy can resolve toidentification and immediately commencing this protocol which ends thethreat. Actual removal of establishedcancers can be conducted as deemed safe.
Dangerous growths can at least besafely reduced to good effect. Braintumors in particular that in clearly inoperative can be reduced throughradiation to relieve the brain of the physical pressure and interference beencaused that made its original presence clear.
The protocol could be evenapplied as a preventative measure to halt low level activity while the immunesystem is boosted to cleanse the body of such threats. In short this is the first leg of adiagnostic and treatment revolution that will preserve the body cancer freethroughout one’s life.
Scientists bring cancer cells back under control
A new treatment for cancer that renders malignant tumours"dormant" has been developed by scientists.
By Richard Alleyne, Science Correspondent 6:30AMGMT 13 Jan 2011
Researchers believe they have found a way of making malignant cancercells benign, stopping them from spreading around the body and so threateninglife.
The revolutionary approach works by switching back on the body'snatural cancer suppressor genes that have been turned off by the disease.
While it does not reduce the tumour that is already formed it stops itspreading around the body.
The team at
have testedthe treatment on animals and have had a 100 per cent success rate andare now hoping to team up with a pharmaceutical company to develop it forhumans. Nottingham University
The Research, published in the Journal Molecular Cancer, reveals how DrCinzia Allegrucci and Dr Andrew Johnson centres around reactivating tumoursuppressor genes.
Ordinarily cell division is controlled by specific genes that kill ormend rogue or damaged cells.
But cancers occur when these go wrong – especially if tumour suppressorgenes are for some reason turned off.
The team used a new technique that involves using proteins fromsalamanders that have been shown in the past to be able to switch on and offhuman genes.
When they were mixed with breast cancer cells, the team were amazedto find they reactivated the cancer suppression genes.
In mice given breast cancer, an injection of the proteins stopped thecancer in its tracks.
Now they want to isolate exactly what proteins were involved in"rebooting" the cells and reproduce them as a drug.
Nell Barrie, science information officer at Cancer Research UK, said:"It's becoming clear that cancer is driven not just by faulty genes but bychanges in cells that help to switch genes on and off.
"This interesting new technique will shed light on how thisprocess contributes to the disease, and further research could one day lead tonew treatments that help to reverse these complex changes in cancercells."